Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

A clinicopathological study of B-cell differentiation markers and transcription factors in classical Hodgkin's lymphoma: a potential prognostic role of MUM1/IRF4

1 Oct 2007

Abstract excerpt

BACKGROUND AND OBJECTIVES: Although most patients with classical Hodgkin's lymphoma (CHL) are cured, a significant minority are refractory to treatment. The investigation of biological markers could improve the predictive capacity of clinical staging systems. The aim of our study was to detect B-cell differentiation markers and transcription factors in CHL in order to define subgroups with different histogeneses...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to HER2/EGFR in Cancer Research
Share to Lymphoma Diagnosis and Treatment

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Source

Identifiers

PMID: 17768115
DOI: 10.3324/haematol.11523

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

A clinicopathological study of B-cell differentiation markers and transcription factors in classical Hodgkin's lymphoma: a potential prognostic role of MUM1/IRF4PMID 17768115Read ↗

B-cell differentiation immunophenotypes in classical Hodgkin lymphomas.Semantic proximity Read ↗

Analysis of the mutational landscape of classic Hodgkin lymphoma identifies disease heterogeneity and potential therapeutic targetsSemantic proximity Read ↗

Diffuse large B-cell lymphomas in adults with aberrant coexpression of CD10, BCL6, and MUM1 are enriched in IRF4 rearrangementsSemantic proximity Read ↗

Gene expression profiling defines molecular subtypes of classical Hodgkin's diseaseSemantic proximity Read ↗

Exploring The Molecular Mechanisms of Classical Hodgkin Lymphoma Through Bioinformatics AnalysisSemantic proximity Read ↗

Molecular profiling of classical Hodgkin lymphoma tissues uncovers variations in the tumor microenvironment and correlations with EBV infection and outcomeSemantic proximity Read ↗

CD10-MUM1+ follicular lymphoma lacks BCL2 gene translocation and shows characteristic biologic and clinical features.Semantic proximity Read ↗

Checkpoint protein expression in the tumor microenvironment defines the outcome of classical Hodgkin lymphoma patientsSemantic proximity Read ↗

Expression of MUM1/IRF4 selectively clusters with primary effusion lymphoma among lymphomatous effusions: implications for disease histogenesis and pathogenesisSemantic proximity Read ↗

Tumor microenvironment and mitotic checkpoint are key factors in the outcome of classic Hodgkin lymphomaSemantic proximity Read ↗

Epigenetic abnormalities of classical Hodgkin lymphoma and its effect on immune escape.Semantic proximity Read ↗

Expression of the human germinal center–associated lymphoma (HGAL) protein identifies a subset of classic Hodgkin lymphoma of germinal center derivation and improved survivalSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.